Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies

Benzer Materyaller

• Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
  Yazar:: Inoue, Kenji, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
  Yazar:: Nakakura, Shunsuke, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
  Yazar:: Inoue, Kenji, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
  Yazar:: Inoue, Kenji, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
  Yazar:: Özkurt, Yelda Buyru, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)